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Abstract
Background: Poor adherence to medication regimens increases adverse outcomes for patients with Type 2
diabetes. Improving medication adherence is a growing priority for clinicians and health care systems. We
examine the differences between patient and provider understandings of barriers to medication adherence
for Type 2 diabetes patients.
Methods: We searched systematically for empirical qualitative studies on the topic of barriers to medication
adherence among Type 2 diabetes patients published between 2002–2013; 86 empirical qualitative studies
qualified for inclusion. Following qualitative meta-synthesis methods, we coded and analyzed thematically the
findings from studies, integrating and comparing findings across studies to yield a synthetic interpretation
and new insights from this body of research.
Results: We identify 7 categories of barriers: (1) emotional experiences as positive and negative motivators to
adherence, (2) intentional non-compliance, (3) patient-provider relationship and communication, (4) information and
knowledge, (5) medication administration, (6) social and cultural beliefs, and (7) financial issues. Patients and providers
express different understandings of what patients require to improve adherence. Health beliefs, life context and lay
understandings all inform patients’ accounts. They describe barriers in terms of difficulties adapting medication
regimens to their lifestyles and daily routines. In contrast, providers' understandings of patients poor medication
adherence behaviors focus on patients’ presumed needs for more information about the physiological and
biomedical aspect of diabetes.
Conclusions: This study highlights key discrepancies between patients’ and providers’ understandings of barriers
to medication adherence. These misunderstandings span the many cultural and care contexts represented by 86
qualitative studies. Counseling and interventions aimed at improving medication adherence among Type 2 diabetes
might become more effective through better integration of the patient’s perspective and values concerning adherence
difficulties and solutions.
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Background
Medication adherence plays an important role in the
clinical care of Type 2 diabetes because it directly con-
tributes to the effectiveness of patients’ treatment and
wellbeing [1, 2]. Diabetes affects a growing number of
patients, and represents one of the primary causes of
death among adult individuals [3, 4]. Diabetes affects
about 382 million people worldwide, of which 85 % to
95 % accountable to Type 2 diabetes in high-income
countries, as well as in low-and-middle income countries
[4]. The prevalence of Type 2 diabetes grows steadily,
due to environmental and behavioural factors such as
economic growth, urbanization, ageing populations, poor
dietary habits, and decreased physical activity [4, 5].
Diabetes is a disease with no specific cure and a de-
manding self-management regimen [4, 5]. It is a progres-
sive condition that requires continuous management as
well as patient and provider collaboration in order to
avoid both short-term and long-term life-threatening
complications [4, 5]. Diabetes management targets op-
timal blood glucose levels, thereby preventing the on-
set and progression of diabetes-related complications
including cardiovascular complications, nerve damage,
kidney failure, eye disease, and diabetic foot, all fac-
tors that can eventually lead to death [3–5]. Effective
Type 2 diabetes management can include adherence
to medication regimens (hypoglycaemic oral tablets
and/or insulin injections), as well as adjustment of
specific life-style behaviours, such as increased phys-
ical activity, adherence to specific dietary regimens,
smoking cessation, and strict monitoring of blood
glucose levels [1, 5].
Although good glycemic control can help to prevent
such complications, diabetes treatment regimens can be
complex. Patients often do not adhere to medication
regimens [1, 2, 6–12]. Non-adherence represents bur-
dens both for patients and for healthcare systems by in-
creasing morbidity and mortality, reducing quality of
life, and raising healthcare costs [1, 2, 6, 9–11]. Trad-
itionally, non-adherence behaviours stem from a pa-
tient’s failure or refusal to comply with the prescribed
medication instructions due to a lack of knowledge or
lack of motivation [7, 9–11, 13]. In this tradition, re-
searchers investigate why patients failed to comply with
providers’ recommendations [7, 13–15]. However, new
perspectives on this topic acknowledge the beneficial
effects on treatment outcomes of a more collaborative
relationship between patient and provider that focuses
on concordance rather than adherence or compliance
with medication regimens. This perspective recognizes
adherence as resulting from a broad set of factors,
and linked to more than just knowledge and motiv-
ation [7, 10, 13, 16]. The shift towards a more patient-
centered model of care recognizes the “empowered
autonomy” of patients as equal and active partners in
care, contributing experiential knowledge to the decision-
making process of care [7, 10, 13, 16]. A patient-centered
approach, then, encourages the use of a negotiated
model of care to foster concordant treatment behav-
iours [7, 9–11, 13, 16].
Acknowledging patients’ voices in the treatment
decision-making process requires deeper understand-
ing of patients’ views of medications, and how these
might differ from the assumptions or values of healthcare
providers. This manuscript synthesizes numerous quali-
tative studies to distil broadly relevant and applicable
insights into better medication adherence. We focus on
patient and provider perceptions of patients’ barriers to
medication adherence, amongst community-dwelling
adults with Type 2 diabetes. In particular, our research
question asks: what barriers to medication adherence
Type 2 diabetes patients and their providers identify?
This synthesis includes 73 studies which include patient
perspectives, 9 studies which include provider perspec-
tives and 4 studies which include both patient and pro-
vider perspectives. Findings reveal the full spectrum of
barriers and facilitators patients face in using diabetes
medications as directed. The four existing studies com-
paring both patient and providers perspectives highlight
some key incongruencies in attitudes and perceptions
towards medication adherence barriers [17–20]. Re-
search findings reveal discrepancies between providers’
conceptualization of quality of health as opposed to the
patient’s idea of overall well-being, as well as different
attitudes to the risk of medication adverse effects [17–20].
However, most of these studies address particular eth-
nic populations, or patient populations with specific co-
morbid conditions, or specific healthcare professional
services, without providing an overall picture of the dif-
ferences between patients and providers. This study
adds to the under-researched literature on the differing
perspectives on medication adherence between patients
and providers. Further, analysis of the differences be-
tween patient and provider perspectives highlights
areas for developing more patient-centered practices to
improve medication adherence.
The topic of this study was informed by the Ontario
Health Technology Advisory Committee’s Expert Advis-
ory Panel on Community Care for Type 2 Diabetes pro-
ject on the improvement of access to, and quality of,
diabetes services and care to enhance prevention and
improving diabetes management. This agency commis-
sioned a report on patient perspectives on barriers and
facilitators to medication adherence. During our ana-
lysis of this data, we noted the discrepancies between
patient and provider perspectives and so returned to
our data to perform a secondary analysis on the current
topic.
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Methods
We provided the methods for the search in detail in
a technical report written with the same data on
medication adherence among Type 2 diabetes patients
for the Ontario Health Technology Advisory Commit-
tee’s Expert Advisory Panel [21]. The report focused
only on patients’ perspectives to barriers and facilita-
tors of medication adherence. We summarize those
methods here.
Literature search
Figure 1 summarizes the systematic bibliographic search
process. We developed a search filter that combined
existing published qualitative filters [22–24] with a
diabetes-topic-specific filter. Because qualitative method-
ology filters have poor specificity, we used exclusionary
terms to improve the precision of the filter (we describe
details elsewhere, available as a CHEPA Working Paper
online at http://www.chepa.org/research-papers/working-
Fig. 1 Flow diagram selection process
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papers or from corresponding author upon request) [21].
We searched OVID MEDLINE, EBSCO Cumulative Index
to Nursing, Allied Health Literature (CINAHL), and ISI
Web of Science Social Sciences Citation Index (SSCI), for
studies published from January 1, 2002 to August 10,
2013. 2002 was chosen to produce a manageable number
of results, and to reflect that the knowledge before this
time was well summarized in the WHO’s 2003 report on
medication adherence [1]. We included papers in English,
available online through McMaster University’s library
system, reporting primary qualitative empirical research,
involved or addressed adults with Type 2 diabetes mellitus
(including papers with both Type 1 and Type 2 diabetes),
and conducted in Canada, the USA, Europe, Australia, or
New Zealand. These countries were chosen because they
have similar levels of resource availability (e.g. diabetes
health care, medications) to Canada. When papers were
not available through the library system of our large,
research-intensive university we made attempts to contact
the authors to request a copy of the paper through infor-
mation available in the abstract/citation or a Google
search. Only 1 paper was unavailable after these attempts
(as shown in Fig. 1). We excluded papers that were un-
published (e.g., reports, theses), not in English, reported
secondary or non-empirical studies, used non-qualitative
methods, or were off-topic (that is, not addressing the
topic of medication adherence). Our search terms were
designed to find qualitative studies about diabetes; further
refinements of the search (e.g. topic of medication adher-
ence, like health care context) were performed manually.
Examples of exclusionary terms include “coefficient” and
“p value”. At least two reviewers independently reviewed
titles, abstracts, and later full papers to determine eligibil-
ity. We reviewed titles and abstracts to identify findings
related to medication adherence, medication and self-
management. We then reviewed the full text of the papers
before inclusion to identify any findings related to medica-
tion adherence. Data extraction was performed by two au-
thors; all authors participated in analysis. Discrepancies
were resolved through conversation between the two au-
thors with a third author participating when an additional
perspective was needed. Studies that included either Type
2 diabetes patients OR both Type 1 and Type 2 diabetes
patients were included. When analyzing studies that in-
cluded participants with both types of diabetes, we consid-
ered the data related to Type 2 diabetes patients when the
authors provided this separately. When no distinction was
made between the data from Type 1 and 2 participants,
we included all data. We included a total of 86 pa-
pers in this synthesis, summarized in Table 1. For a
detailed list and description of the main focus of each
study see Table 2.
We used the integrative technique of qualitative meta-
synthesis to analyze our data [25–27]. Qualitative meta-
synthesis aims to both summarize a range of findings
across studies while retaining the original meaning
and to compare and contrast findings across studies
to produce a new integrative interpretation [28]. Ana-
lytical integrative meta-synthesis combines and synthe-
sizes findings in new interpretative ways, while preserving
the differences and complexities of the topic under study.
Congruent with this meta-synthesis methodology, we
started with a pre-defined topic and research question,
which guided data collection, extraction of findings, and
analysis. We retrieved all qualitative research relevant to
this research question. Critical appraisal remains contro-
versial for qualitative research methodology, in part be-
cause there is a lack of consensus in the field about what
constitutes high quality research [29]. Procedural detail is
typically under-reported, but even when reported and
achieved, methodological procedures do not always guar-
antee to useful results [27, 29]. Accordingly, we followed
current conventions in qualitative meta-synthesis and nei-
ther appraised nor excluded papers on the basis of any










United Kingdom 16 18.6
Othera 6 6.9
United States 43 50
Study Participants N %
Patients only 72 83.7
Patients and providers 5 5.8
Providers only 9 10.5
Qualitative Methodologies N %
Content analysis 7 8.1
Ethnography 4 4.7
Grounded theory 17 19.8
Otherb 8 9.3
Phenomenological 4 4.7
Qualitative (otherwise unspecified) 46 53.4
a “Other” countries include: Multi-country studies, Germany, Norway,
Belgium, Croatia
b “Other” methods include: linguistic analysis (1), discourse analysis (1),
narrative analysis (1), participatory action (1), framework analysis (1), and
cognitive task analysis (3)
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Table 2 Detailed list and description of the main focus of each study
AUTHOR DATE TITLE COUNTRY METHODOLOGY PARTICIPANTS MAIN RESEARCH QUESTION
Ab et al. 2009 Reasons of general practitioners
for not prescribing lipid-lowering
medication to patients with
diabetes: a qualitative study
Netherlands Qualitative; Interviews 7 family physicians What factors underlie GPs’ decisions
not to prescribe lipid-lowering
medications to patients with T2DM?
Adili et al. 2012 Inside the PAR group: The group





11 patients with T2DM,
women, older population
What is the value of group learning
in helping women to live with T2DM?
Agarwal et al. 2008 GPs’ approach to insulin prescribing





21 family physicians What are the themes that reflect factors
that influence the prescribing of insulin
when treating older patients with T2DM?
Barko et al. 2011 Perceptions of diabetes symptoms




20 patients with T2DM,
Slavic immigrants and White
non-immigrants, women,
older population
What are the similarities and differences
between perceived symptoms of T2DM
and self-management strategies for
Russian-speaking Slavic immigrant
American women and non-Hispanic,
non-immigrant White American women?
Barton et al. 2005 The diabetes experiences of




8 patients with T2DM, Aboriginal What are the experiences of Nuxalk
people living with the challenges of
T2DM, and how can these experiences
inform health services in culturally
specific ways?
Bhattacharya et al. 2012 Psychosocial Impacts of Type 2




31 patients with T2DM,
African American
What are participant motivations for
making health behavior changes?
Bhattacharya et al. 2012b Self-management of type 2 diabetes
among African Americans in the




31 patients with T2DM,
African American
What are the underlying factors
influencing the promotion of T2DM?
Bissell et al. 2004 From compliance to concordance:
barriers to accomplishing a re-framed
model of health care interactions
UK Qualitative (Grounded
theory); Interviews
21 patients, Pakistani What are the barriers to accomplishing
a re-framed model of interactions
between HPs and patients?
Bogatean et al. 2004 People with type 2 diabetes facing
the reality of starting insulin therapy:





18 patients with T2DM What are the factors involved in
psychological insulin resistance?
Borgsteede et al. 2011 Factors related to high and low levels
of drug adherence according to
patients with type 2 diabetes
Netherlands Qualitative; Interviews 20 patients with T2DM What are the factors related to high
and low levels of drug adherence
according to patients with T2DM in
primary care?
Borovoy Hine 2008 Managing the unmanageable: elderly
Russian Jewish émigrés and the
biomedical culture of diabetes care




What is the apparent resistance of
elderly Russian Jewish émigrés to














Table 2 Detailed list and description of the main focus of each study (Continued)
Broom & Whittaker 2004 Controlling diabetes, controlling
diabetics: moral language in the
management of diabetes type 2
Australia Qualitative; Interviews 119 patients with T2DM;
56 service providers
How is moral identity negotiated
(through a language of control,
surveillance, discipline, and responsibility)
in the efforts to integrate, live with, and
control T2DM?
Brown, J et al. 2002 The role of patient, physician and
systemic factors in the management
of type 2 diabetes mellitus
Ontario,
Canada
Qualitative; Focus groups 30 Family physicians What are the contextual dimensions and
subsequent interactions that contribute
to a lack of adherence in the application
of guidelines for T2DM?
Brown, K et al. 2007 Health beliefs of African-Caribbean
people with type 2 diabetes: a
qualitative study
UK Qualitative; Interviews 16 patients with T2DM,
African-Caribbean
How do health beliefs influence the
way African–Caribbean people with
T2DM manage their illness?
Burke et al. 2006 Patients with diabetes speak:
Exploring the implications ofpatients’




8 patients with T2DM How might physicians use information
about patients’ perspectives to
improve patients’ self-management
of T2DM and thereby their glycemic
control?
Cardol et al. 2012 People with mild to moderate
intellectual disability talking about
their diabetes and how they manage
Netherlands Qualitative; Interviews 17 patients with T1DM +
T2DM, Intellectual Disability
How do people with Intellectual
Disability experience having diabetes
and how do they manage the
condition? How can understanding
this information support in the
engagement of self-management
activities?
Connor et al. 2012 Listening to patients’ voices: linguistic




43 patients with T2DM What are the most prominent linguistic
indicators of two constructs that have
been found to be important factors in
models of health self-management:
control orientation and agency?
Coronado et al. 2004 Attitudes and beliefs among Mexican
Americans about type 2 diabetes
USA Qualitative; Focus groups 42 patients with T2DM, Mexican
Americans
Knowing that Hispanics in the United
States are at a disproportionately high-
risk for T2DM, what are the attitudes
and beliefs about diabetes among this
group?




44 patients with T2DM How do patients’ self-management
beliefs and practices affect the nature
of key diabetes care office visit decisions?
Courtenay et al. 2010 The views of patients with diabetes
about nurse prescribing.
UK Qualitative; Interviews 41 patients with T1DM +
T2DM
What are the views of patients receiving
prescriptions from Nurse Practitioners
and what are the advantages and
disadvantages of NP’s prescribing this
medication?




21 caregivers of patients
with co-morbid T2DM and
dementia
What are caregivers’ challenges and
quality-of-life issues managing diabetes













Table 2 Detailed list and description of the main focus of each study (Continued)
Felea et al. 2013 Perceptions of Life Burdens and of
the Positive Side of Life in a Group
of Elderly Patients with Diabetes: A




57 patients with T2DM,
older population
What are the main concerns of frail
elderly people diagnosed with diabetes
in terms of the perception of their
burdens and their distinctive views
on the positive side of life?
Frandsen &
Kristensen






123 patients with T2DM According to patients across four
European countries and the United
States, what are the issues and barriers
related to diet, lifestyle, and medication
adherence?
Garrett & Martin 2003 The Asheville Project: participants’
perceptions of factors contributing
to the success of a patient
self-management diabetes program
USA Qualitative; Focus groups
and interviews
21 patients with T1DM +
T2DM; 4 pharmacists; 1
diabetes educator; 6
project managers
What are patients’, providers’, and
managers’ perceptions of the factors
that contributed to the success of the
Asheville Project: a Patient Self-
Management Diabetes Program?
Gazmararian et al. 2009 Perception of Barriers to Self-care
Management Among Diabetic
Patients
USA Qualitative; Focus groups 35 patients with unspecified
DM, African-American,
economically disadvantaged
What are the individual, educational,
and system barriers that limit low-
income diabetes patients’ ability to
achieve optimal diabetes self-
management?








What are the experiences and
perceptions of self-management of
diabetes as narrated by older people
diagnosed with insulin-dependent
diabetes living in a rural area?
Goering & Mathias 2010 Coping with chronic illness: information




21 patients with T2DM How can we understand the complex
relationship among information usage,
medication adherence, and disease
management in people with T2DM?
Gorawara-Bhat et al. 2008 Communicating with older diabetes




28 patients T2DM, elderly
population
As healthcare goals and self-
management behaviors are frequently
shaped through social comparisons
with peers/family members, what is
the role of social comparison in older
patients with T2DM?
Grant et al. 2011 Diabetes oral medication initiation
and intensification: patient views




50 patients with T2DM What are patient perceptions about
medication management principles
underlying American Diabetes
Association (ADA) published treatment
algorithms?
Guell 2012 Self-care at the margins: meals and




17 healthcare providers; 7
patients with T2DM,
Turkish migrants
What are Turkish migrants’ everyday
practices of diabetes self-management
in Berlin, Germany?
Hayes et al. 2006 Understanding diabetes medications
from the perspective of patients with




138 patients with T2DM What are patient’s perceptions of














Table 2 Detailed list and description of the main focus of each study (Continued)
Heisler et al. 2009 Participants’ Assessments of the Effects
of a Community Health Worker
Intervention on Their Diabetes Self-
Management and Interactions with
Healthcare Providers
USA Qualitative; Interviews 40 patients with T2DM,
African-American and
Latino
How does the program influence
participants’ diabetes care and
interactions with healthcare providers,
and what gaps, if any, does it address?
Helsel et al. 2005 Chronic illness and Hmong shamans USA Qualitative (grounded
theory); Interviews
11 patients with T2DM or
hypertension, Hmong
Shaman
How do Hmong Shamans’ understand
and manage their chronic illness, and
how can this perspective be used as a
gateway to understanding how the
broader Hmong American community
perceive these conditions?




30 patients with T2DM,
American Indian elders
What are the belief systems about diabetes
in American Indian elders, and what are
the effects of culture on care-seeking,
adherence, and diabetes self-care?
Hinder & Greenhalgh 2012 “This does my head in”. Ethnographic
study of self-management by people
with diabetes
UK Ethnographic study; Shadowing,
interviews, observation
30 people with T1DM +
T2DM
Why is self-management of diabetes
challenging for some, and how can
research produce a richer understanding
of how people live with diabetes?
Ho & James 2006 Cultural barriers to initiating insulin
therapy in Chinese people with type





5 patients with T2DM,
Chinese-Canadian, insulin
dependent
What are some of the cultural barriers
(as influenced by factors specific to the
Chinese culture) to initiating insulin
therapy among Chinese individuals
with T2DM living in Canada?
Holmstrom &
Rosenqvist
2005 Misunderstandings about illness and





18 patients with T2DM,
Swedish
What are the specific misunderstandings
that Swedish patients with T2DM have
about their illness and treatment, and
how can health care services support
rather than obstruct self-care and
learning?
Hornsten et al. 2011 A model of integration of illness and
self-management in type 2 diabetes
Sweden Qualitative (content analysis);
Narrative interview
44 patients with T2DM,
Swedish-speaking
What is the process of illness integration
and self-management among people
with T2DM?
Hu et al. 2012 The Meaning of Insulin to Hispanic
Immigrants With Type 2 Diabetes
and Their Families
USA Qualitative (content analysis);
Focus groups
43 patients with T2DM,
Hispanic
What is the meaning of Insulin among
a sample of Hispanic immigrants with
T2DM and their family members/
significant others, and what strategies
and further research are necessary to
dispel negative perceptions and
facilitate positive experiences?
Huang et al. 2005 Self-reported goals of older patients
with type 2 diabetes mellitus
USA Qualitative (grounded theory);
Interviews
28 patients with T2DM,
elderly population
What are the self-reported healthcare
goals, factors influencing these goals,
and self-care practices of older patients
with T2DM, and how can this
knowledge support providers in
communicating with older patients













Table 2 Detailed list and description of the main focus of each study (Continued)
Hunt et al. 2012 The changing face of chronic illness
management in primary care: a
qualitative study of underlying
influences and unintended outcomes
USA Qualitative; Interviews and
observations
58 clinicians and 70
patients with T2DM and
hypertension, observations
of 107 clinical consultations
with 12 clinicians
Due to the recent and dramatic
increase in the diagnosis and
pharmaceutical management of
common chronic illnesses, how can
qualitative data collected in primary
care clinics help assess how these
trends play out in clinical care?
Jeavons et al. 2006 Patients with poorly controlled
diabetes in primary care: healthcare
clinicians’ beliefs and attitudes
UK Qualitative; Focus groups 23 healthcare providers
(family physicians and
nurses)
What are doctors’ and nurses’ attitudes
and beliefs about treating patients with
T2DM with less than ideal glycemic
control while receiving maximal oral
treatment in primary care?
Jenkins et al. 2011 Participants’ experiences of
intensifying insulin therapy during
the Treating to Target in Type 2
Diabetes (4-T) trial: qualitative
interview study
UK Qualitative (grounded theory);
Interviews
41 patients with T2DM,
insulin dependent
What are participants’ experiences of
intensifying insulin therapy during the
Treating to Target in Type 2 Diabetes
(4-T) trial, and specifically, how do
participants’ manage anxiety around
increased likelihood of injecting insulin
in public places?
Klein & Lippa 2012 Assuming control after system failure:
type II diabetes self-management







How do patients bridge the gap
between existing education programs
and the real, dynamic challenges of
diabetes self-management?
Klein & Meininger 2004 Self Management of Medication and
Diabetes: Cognitive Control




What self-management problems do
Type 2 diabetic patients face?
Lamberts et al. 2010 The role of the community
pharmacist in fulfilling information
needs of patients starting oral
anti-diabetics
Netherlands Qualitative; Interviews and
focus groups
42 patients with T2DM What are the information needs of
patients who have recently started
treatment with oral anti-diabetics and
what are the opportunities for
pharmacy regarding the provision of
information for patients with T2DM?
Lawton et al. 2005 Perceptions and experiences of
taking oral hypoglycaemic agents
among people of Pakistani and
Indian origin: qualitative study
UK Qualitative (grounded theory);
Interviews
32 patients with T2DM,
British Indian or Pakistani
What are British Pakistani and British
Indian patients’ perceptions and
experiences of taking oral hypoglycemic
agents (OHAs), and how does
ambivalence toward Western drugs
influence medication adherence?
Lawton et al. 2008 Patients’ perceptions and experiences
of taking oral glucose-lowering




20 patients with T2DM What are patient expectations,
perceptions and experiences of oral
glucose-lowering agents (OGLAs),
including their reasons for taking/not
taking these drugs as prescribed and
what recommendations exist for














Table 2 Detailed list and description of the main focus of each study (Continued)
Lee et al. 2007 The development and evaluation of
written medicines information for
type 2 diabetes
Australia Qualitative; Interviews 24 patients with T2DM Using the ‘Consumer Involvement
Cycle’ to investigate consumer
perspectives and the need for
medication information for patients
with T2DM, how can this information
be used to develop appropriate WMI
for the T2DM population?
Lippa & Klein 2008 Portraits of patient cognition: how
patients understand diabetes self-care
USA Qualitative; Interviews 18 patients with T2DM How do T2DM patients with low,
moderate, and good glycemic
control conceptualize self-care?
Lippa et al. 2008 Everyday expertise: cognitive demands
in diabetes self-management
USA Qualitative (cognitive task
analysis); Interviews
18 patients with T2DM What is the relationship between
decision-making and successful
diabetes self-management?
Lutfey 2005 On practices of ‘good doctoring’:
reconsidering the relationship
between provider roles and patient
adherence







How do medical practitioners
conceptualise, tailor their actions,
and strategically enact practices
with specific patients in order to
maximise their adherence to
treatment regimens?
Lynch et al. 2012 Concepts of diabetes self-
management in Mexican American
and African American low-income
patients with diabetes
USA Qualitative (grounded theory);
Focus groups
84 patients with T2DM,
African American and
Mexican American
How do low-income minority
conceptualize diabetes self-
management and to what extent
do patient beliefs correspond to
evidence-based recommendations?
Mathew et al. 2012 Self-management experiences
among men and women with type 2





35 patients with T2DM What are the differences in diabetes
self-management - specifically needs,
barriers and challenges among men
and women living with T2DM?
Mayberry & Osborn 2012 Family support, medication adherence,
and glycemic control among adults
with type 2 diabetes
USA Mixed method: Qualitative;
Focus groups; quantitative;
Surveys
45 patients with T2DM
(n = 61 for surveys)
Does the perception of family
members’ knowledge about
diabetes have a positive or
negative association with patients’
diabetes-specific supportive
behaviors and medical adherence?
McSharry et al. 2013 ‘The chicken and egg thing’:
cognitive representations and self-
management of multimorbidity in
people with diabetes and depression
UK Qualitative; Interviews 17 patients with T1DM +
T2DM and depression
How do patients perceive and
report the impact and management
of multimorbid representations of
diabetes and depression?
Mishra et al. 2011 Adherence to Medication Regimens
among Low-Income Patients with
Multiple Comorbid Chronic Conditions
USA Qualitative; Focus groups 50 patients with T1DM +
T2DM, 40+ years of age,
2+ chronic conditions
What are the facilitators and
barriers for adherence to multiple
medications among low-income
patients with comorbid chronic
physical and mental health
conditions?
Mohan et al. 2013 Illustrated medication instructions as
a strategy to improve medication
USA Qualitative; Focus groups
and interviews
38 patients with T2DM,
Latino
What are the barriers to effective
medication management for Latino













Table 2 Detailed list and description of the main focus of each study (Continued)
management among Latinos: a
qualitative analysis
strategies could help improve
medication management among
this vulnerable population?
Morris et al. 2005 Experiences of people with type 2
diabetes who have changed from
oral medication to self-administered
insulin injections: a qualitative study
UK Qualitative; Interviews 6 patients with T2DM,
older population
What are the lived subjective
experiences, expectations, and
impact for patients who have
recently started insulin?
Morrow et al. 2008 Integrating diabetes self-management
with the health goals of older adults:
a qualitative exploration.
USA Qualitative; Interviews 24 patients with T2DM,
hypertension, and at
least one other chronic
comorbidity, elderly
population; 10 caregivers
What are the life and health goals
of older adults with diabetes, and
what are the factors that influence
their diabetes self-management?
Moser et al. 2008 Self-management of type 2 diabetes
mellitus: a qualitative investigation
from the perspective of participants




15 patients with T2DM,
elderly population
How do patients with T2DM
experience self-management in
a nurse-led shared care program?
Nagelkerk et al. 2006 Perceived barriers and effective
strategies to diabetes self-management
USA Qualitative (content
analysis); Focus groups
24 patients with T2DM,
rural
What do patients perceive as
barriers and effective strategies
for self-management in a rural
setting?
Nair et al. 2007 “I take what I think works for me”: a
qualitative study to explore patient






18 patients with T2DM What is the experience of benefit
and risk assessment for people
with T2DM when making
treatment decisions?
Noakes 2010 Perceptions of black African and
African-Caribbean people regarding
insulin
UK Qualitative; Focus groups 13 patients with T2DM,
African and African-
Caribbean
What are black African and
African-Caribbean adults’
perceptions of insulin treatment?
Onwudiwe et al. 2011 Barriers to self-management of diabetes:
a qualitative study among low-income
minority diabetics
USA Qualitative; Focus groups 31 patients with T2DM,
predominantly African-
American, low income
What do low income minority
patients perceive as barriers to
self-management?
Parry et al. 2006 Issues of cause and control in patient
accounts of Type 2 diabetes.
UK Qualitative (discourse
analysis); Interviews
40 patients with T2DM How do patients view diabetes
services and disease causation
and management, and what are
the implications of these beliefs
for clinical management?
Patel et al. 2012 Insulin initiation and management in
people with Type 2 diabetes in an
ethnically diverse population: the
healthcare provider perspective.
UK Qualitative; Interviews 14 healthcare professionals
who care for patients with
T2DM
What are barriers to prescribing
insulin to multi-ethnic adults
(mostly South Asian setting) with
T2DM?
Phillips 2007 Starting patients on insulin therapy:
diabetes nurse specialist views
UK Qualitative (exploratory);
Interviews
4 diabetes nurse specialists What are the challenges of














Table 2 Detailed list and description of the main focus of each study (Continued)
Rahim-Williams 2011 Beliefs, behaviors, and modifications
of type 2 diabetes self-management




25 patients with T2DM,
women, African American
What are the health beliefs and
behaviours affecting self-
management of African American
women with T2DM?
Raphael et al. 2012 A toxic combination of
poor social policies and programmes,
unfair economic arrangements and bad
politics: the experiences of poor
Canadians with Type 2 diabetes
Ontario,
Canada
Qualitative; Interviews 60 patients with T2DM,
low income
What are the day to day
experiences of low income
adults with T2DM living in
poverty?
Rayman & Ellison 2004 Home alone: the experience of women




14 patients with T2DM,
women
What are the early experiences
of women learning intensive
self-management of T2DM?
Renfrew et al. 2013 Barriers to Care for Cambodian Patients
with Diabetes: Results from a Qualitative
Study
USA Qualitative; Focus groups 15 patients with T2DM,
Cambodian; 25 clinicians;
5 bilingual Khmer staff
What are potential barriers to care
for Cambodian patients with T2DM?
Rise et al. 2013 Making and Maintaining Lifestyle
Changes after Participating in Group
Based Type 2 Diabetes Self-Management
Educations: A Qualitative Study.
Norway Qualitative (Phenomenological);
Focus groups and interviews
23 patients with T2DM How do patients make and maintain
lifestyle changes after participating
in group-based self-management
education for T2DM?
Shaw et al. 2013 Resources, roadblocks and turning
points: a qualitative study of American
Indian/Alaska Native adults with type 2
diabetes
USA Qualitative; Focus groups
and interviews
13 patients with T2DM,
Alaska Native and
American Indian
What are the perceived psychosocial
needs and barriers to self-management
for Alaskan Native and American
Indian adults with T2DM?
Stack et al. 2008 A qualitative exploration of multiple
medicines beliefs in co-morbid
diabetes and cardiovascular disease





What are the perceptions of multiple
medications expressed by patients
managing co-morbid T2DM and
cardiovascular disease?
Thorlby et al. 2011 Clinicians’ views of an intervention to
reduce racial disparities in diabetes
outcomes
USA Qualitative; Interviews 12 physicians; 4 nurse
practitioners; 1 physician
assistant
What do primary care practitioners
understand about racial disparities
among patients with T2DM and
what are the perceptions of a cultural
competency intervention?
Tjia et al. 2008 Beneath the surface: discovering the
unvoiced concerns of older adults
with type 2 diabetes mellitus
USA Qualitative; Interviews 22 patients with T2DM,
older population, at least
5 medications
What are the concerns of older




2013 Social and health care provider
support in diabetes self-management.
USA Qualitative; Interviews 30 patients with T2DM,
Asian Indian immigrants
What social and health care support
do Asian Indian adults with T2DM
have for self-management?
Vermeire et al. 2007 Obstacles to adherence in living with
type-2 diabetes: an international






246 patients with T2DM What barriers do patients with T2DM
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Vinter-Repalust et al. 2004 Obstacles which patients with type 2
diabetes meet while adhering to the
therapeutic regimen in everyday life:
qualitative study
Croatia Qualitative (content analysis);
Focus groups
49 patients with T2DM What is the experience of T2DM, what
are expectations of the health care
system, and what barriers to adhering
to the therapeutic regimen are
encountered?
Wan et al. 2012 Conceptualizations of patient
empowerment among individuals
seeking treatment for diabetes
mellitus in an urban, public-sector
clinic.
USA Qualitative; Interviews 29 patients with T2DM How do patients perceive patient
empowerment as it applies to
treatment, interactions with HPs
and self-management?
Wang et al. 2012 Focus group study assessing self-
management skills of Chinese
Americans with type 2 diabetes
mellitus
USA Qualitative; Focus groups 24 patients with T2DM,
Chinese-American
What beliefs, experiences, knowledge
and skills facilitate self-management
among Chinese-American adults with
T2DM?
Wens et al. 2005 GPs’ perspectives of type 2 diabetes
patients’ adherence to treatment: A





40 family physicians What are the thoughts and feelings
of FPs about T2DM patient compliance/
adherence?
Williams et al. 2008 Adherence to multiple, prescribed
medications in diabetic kidney
disease: A qualitative study of





23 patients with T2DM and
chronic kidney disease; 16
healthcare professionals
What factors affect adherence to
multiple prescription medications
for patients with co-morbid T2DM
and diabetic kidney disease?
Wilson et al. 2013 Patient and carer experience of
obtaining regular prescribed
medication for chronic disease
in the English National Health
Service: a qualitative study
UK Qualitative; Interviews 21 patients with T1DM + T2DM
and other chronic conditions; 9
caregivers
What are patient and caregiver
experiences of community and
primary care services for chronic
disease, especially service delivery
of repeat prescriptions?
Wong et al. 2005 Perspectives on clinic attendance,
medication and foot-care among
people with diabetes in the Torres
Strait Islands and Northern Peninsula
Area
Australia Qualitative (descriptive);
Interviews and focus groups
67 patients with T2DM,
Indigenous Torres Strait
Islanders
What are the perspectives and
needs of indigenous people with
T2DM? How might successful self-
management be promoted in this
group?













superficial indicators of quality other than excluding pa-
pers which did not provide evidence to support their
stated findings [25, 26, 28, 30–34].
The data extraction phase involved identifying findings
relevant to the topic, focusing on the authors’ secondary
interpretations – i.e., the authors’ “data-driven and inte-
grated discoveries, judgments, and/or pronouncements
researchers offer about the phenomena, events, or cases
under investigation” [26]. Primary data makes ad hoc ap-
pearances in qualitative reports; while we did not focus
our analysis on these excerpts per se, we did extract par-
ticipant quotes when useful for illustrative purposes.
We analyzed our data using a staged coding process
similar to grounded theory, [35, 36] breaking findings
into their component concepts and then grouping and
re-grouping those findings across studies according to
inductively identified themes. First, FM, MV, and DH
coded the same sources of data (the 86 articles) and
identified the preliminary categories. Categories were
formed based on both prevalence of information across
a large number of studies and usefulness or importance
of information in a smaller number of studies. These
categories provided the foundation for our interpretive
insights of medication adherence across the body of re-
search. We used a constant comparative and iterative
approach, in which we compared preliminary categories
with the research findings, raw data excerpts, and co-
investigators’ interpretations of the studies. FM, MV,
and DH met regularly to discuss the analytical findings
and the next analytical steps. Finally, all the authors
jointly negotiated the final emerging analytical themes.
All authors participated in the overall analytical process,
meeting regularly to discuss the iterative process of ana-
lysis, compare findings and interpretations, and decide
how to move forward.
Results
The 86 included studies involved 2797 individuals with
Type 2 diabetes, 40 caregivers, and 356 clinicians. The in-
tegrative analysis of these studies provides rich findings
concerning how patients and providers perceive barriers to
medication adherence. We organize these findings into 7
categories of barriers and facilitators: (1) emotional experi-
ences as positive and negative motivators to adherence, (2)
intentional non-compliance, (3) patient-provider relation-
ship and communication, (4) information and knowledge,
(5) medication administration, (6) social and cultural
beliefs, and (7) financial issues. For each, we describe how
patients and providers understand the barriers, and high-
light key areas of congruent vs. divergent understandings.
Emotions increasing and decreasing adherence
Both positive and negative emotions can impair or pro-
mote medication adherence. Positive emotions, such as
experiencing positive health benefits of insulin treatment
[37–41], can reinforce self-reported feelings of empower-
ment [37–41], and the ability to follow-through with
self-care [40, 42–44]. Emotional and social support pro-
mote a sense of self-efficacy and commitment to lifestyle
changes [22, 45–52], encouraging patients to do better
and stay “on track” [46, 48–58].
Negative emotions such as fear, self-blame, guilt, shock,
helplessness, and frustration can also either raise or lower
adherence. Patients frightened by symptoms returning,
early death, and potential complications of diabetes some-
times become more serious about medication adherence
[41, 47, 58–66]. Observing the suffering of others with
diabetes complications can motivate patients to adhere
strictly to their own treatments [51, 59, 67].
However, some patients prefer providers to
emphasize the potential benefits of adhering, rather
than the risks of non-compliance [41, 43, 44, 58].
Those with increasing complications and intensifying
treatment sometimes feel they have already failed at
managing the disease, creating a “vicious circle of low
motivation” [41, 61, 68–74]. Distress – whether from
diabetes or other sources – can also demotivate medi-
cation adherence [71, 75, 76]. Co-morbid conditions,
such as heart disease, hypertension, depression, kidney
failures, decreasing sight [22, 44, 50, 57, 66, 68, 77–79]
can also lead to stress and complicate self-management
practices [17, 22, 50, 57, 58, 66, 68, 77–80]. However,
co-morbidities can have the opposite effect of increas-
ing motivation as successful self-management promotes
self-confidence [44, 45, 52, 58, 81].
Healthcare professionals peripherally address the theme
of emotions in conversations of motivation, explicitly at-
tributing poor adherence to patients’ lack of motivation,
even when providers do not explicitly discuss the impact
of emotions on motivation [75, 82–85].
While patients’ motives are deep rooted and difficult
to modify [85], providers echo patients’ perspectives on
the influence of symptoms in adherence behaviours
[78, 82]. Asymptomatic patients adhere less consist-
ently to medication [58, 83, 86]. In contrast, patients
who feel unwell, thus frightened, convert to insulin
therapy more willingly [86]. Some providers use insu-
lin as a threat to motivate their patients to improve
adherence [41, 58]. Providers, as patients, also recognize
that symptom improvement motivates patients [82], ac-
knowledging the motivating effect of positive emotions re-
lated to empowerment and success [78].
Intentional non-adherence
Some patients intentionally and purposefully do not follow
their medication regimens. We conceptualize intentional
non-adherence as the patients’ refusal to adhere to a spe-
cific medication regimen. Patients’ beliefs and attitudes
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toward the health care system can promote informed
and not informed intentional non-compliant behav-
iours [17, 43, 50, 78, 87–89].
Intentional non-adherence sometimes results from denial
about the seriousness of diabetes [47, 57, 65, 68, 77, 90].
Denial of the severity of diabetes may relate to the
belief that “everybody’s got it” [90], or to the under-
lying scepticism and lack of trust about the effective-
ness of the treatment coupled with the fear that the
prescribed medication is unnecessary, unhealthy, or
dangerous [44, 50, 80, 89, 91]. Most commonly pa-
tients decide not to adhere to medication regimens as an
effort to avoid side effects [50, 67, 68, 78, 79, 89, 92–94].
This type of intentional non-compliance often takes a trial
and error approach, with the patient self-adjusting medi-
cation (i.e. doses and timings) [17].
Providers in several studies describe a scenario
where patients agree to take the medication, but then
do not follow through for unclear reasons despite
provider’s “best detective work” [75, 95]. Providers
ascribe different motivations to this behaviour, including
cultural motives (e.g. preference for traditional medica-
tion), financial constraints, depression, and poor cognitive
ability [17, 85]. However, we found no evidence that pro-
viders recognize that intentional non-adherence may re-
sult from a patient's attempt to mitigate unpleasant
medication side effects.
Patient-provider relationship and communication
Many studies address the nature of the relationship
between patients and health care providers and how
this relationship affects medication adherence and self-
management practices either positively or negatively
[17–20, 37–44, 48–60, 62, 64–70, 72, 73, 75, 76, 78,
81, 89, 91, 93, 94, 96–109]. Patients describe their re-
lationship with their provider in relation to several types
of facilitators, including health care professionals’ support,
collaboration and improved communication strategies
[17–19, 38, 39, 41–44, 48–54, 57–59, 62, 64–70, 72, 73,
76, 78, 81, 93, 94, 96–105]. However, many patients re-
mark on the disconnect between treatment recommenda-
tions and their everyday life, as well as perceptions of lack
of support, communication barriers, challenges of working
with culturally insensitive providers, and barriers to acces-
sing health care providers, such as time constraints during
visits [17, 18, 20, 37–40, 42–44, 48, 50, 52–56, 59, 60, 62,
64, 68–70, 72, 73, 75, 76, 78, 81, 89, 91, 93, 94, 96–99,
101, 102, 105–109]. In particular, patients describe a desire
to be “perceived as persons, not illnesses” [66, 75, 81].
Without the understanding of patient’s life contextual fac-
tors, providers may set unrealistic targets, which patients
deem impossible, thus frustrating [17, 44, 69, 75, 91, 99].
Patients attribute providers’ unrealistic expectations to a
lack of support or disinterest, which results in feelings of
distrust [17, 18, 44, 52, 59, 69, 75, 91, 96, 97, 99, 107].
Many patients report hope for a collaborative relationship
based on mutual trust and agreement between patient and
provider, which would allow them to openly discuss their
challenges and concerns with the providers [17, 18, 39,
41–44, 48, 50, 52, 57, 58, 66–68, 70, 72, 73, 78, 92–94, 96,
100–102]. Both non-marginalized and socially and cultur-
ally marginalized patients, such as indigenous groups, im-
migrants, and visible minorities stress the importance of
their relationship with the provider. Although each
population group focuses on different aspects of such
relationships, both groups place great value on the
patient-physician relationship as a beneficial factor for
medication adherence. Marginalized groups describe is-
sues such as language and cultural barriers while non-
marginalized groups focus on systemic barriers to
building a positive relationship, such as long wait times
for short appointments.
Patients consider providers the major and most reli-
able source of information about their condition and
their treatment [19, 38, 39, 43, 48, 49, 52–54, 57–59, 64,
66, 70, 76, 78, 93, 94, 96–98, 102, 104]. However, com-
munication barriers may inhibit collaborative relation-
ships, preventing a shared understanding of treatment
and therefore hindering medication adherence [17, 20,
40, 42, 43, 48, 50, 52, 53, 55, 60, 64, 65, 68, 70, 72, 73,
76, 78, 81, 91, 94, 97, 99, 105–108]. Authors describe the
barriers to communication between patients and pro-
viders as reflecting differences in underlying health be-
liefs and different desires and understandings of the
model of care [17, 20, 40, 42, 43, 48, 50, 52, 53, 55, 56,
59, 60, 64, 65, 68, 70, 76, 81, 91, 93, 96, 98, 99, 101,
105–107]. Patients attribute communication barriers to
the way clinicians communicate with them, including
providing information that is ambiguous, incomplete, or
irrelevant, provider time constraints, and lack of shared
decision-making strategies among multiple health care
providers [17, 20, 40, 42, 43, 48, 50, 52, 53, 55, 60, 64,
65, 68, 70, 72, 73, 76, 78, 81, 91, 94, 97, 99, 105–108]. In-
formation inconsistency [17, 50, 68, 70, 81, 97, 105] and
lack of clear information may result in misunderstand-
ings, and lead patients to use other sources of informa-
tion [22, 42, 43, 48, 50, 53, 55, 56, 68, 70, 73, 76, 91, 98,
99, 105–108]. Patients find nurses or pharmacists more
accessible for information or to answer questions about
medication [17, 19, 43, 51, 98, 105]. As briefly men-
tioned earlier, patients’ language and cultural barriers, as
well as their low health literacy levels inhibit communi-
cation between patient and provider [20, 42, 43, 50, 55,
56, 59, 64, 70, 72, 78, 93].
Providers, while acknowledging the contributions of a
collaborative model of care, address systemic, structural,
cultural, and linguistic barriers to patient-provider rela-
tionships that impact medication adherence [17, 66, 75,
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82–85, 95, 98, 110–112]. In particular, providers
recognize different ways in which they may affect patient
adherence, including poor “detective work” when devis-
ing treatment regimens, poor negotiation abilities, delay
in starting insulin therapy, cultural insensitivity, incor-
rect a priori assumptions about patient knowledge and
understanding of the treatment, as well as feelings of
powerlessness and frustration which affects the health-
care professionals’ ability to provide adequate recom-
mendations [17, 75, 84, 85, 112].
Health care providers also identify patient- related
factors affecting their relationship, such as: patients’
passive role, communication barriers, cultural barriers,
patients’ distrust in the provider, intentional non-
compliance, and patients’ low health literacy levels
[20, 83, 84, 95, 110, 112]. Providers describe patients’
passive behaviour as stemming from patients’ negative
past clinical encounters, distrust in healthcare pro-
viders, deferential attitudes, or patients’ misinformed
expectations [20, 83–85, 112]. Most importantly, clinicians
value addressing patients’ needs, in order to “figure out”
and”fix” reasons for non-compliance [66, 75, 82, 84, 85, 95].
Sometimes providers address the negative impact of
structural and language barriers to patient-provider
communication – which in turn hinders medication
adherence [17, 20, 85, 95, 110]. Systemic problems in-
clude long waiting lists, busy schedules, and practice
organization barriers, which limit physicians’ available
time to communicate with patients [20, 95, 110]. In
particular, time constraints and systemic barriers delay
their decision to start treatment therapies (e.g. insulin),
which need several clinical encounters to adequately in-
struct patients [84, 95, 110].
Information & knowledge
Patient accounts of how they negotiate their medication
regimens offer explanations for why they choose to man-
age their condition in a way that suits their personal cir-
cumstances and understanding of their health, body, and
diabetes [60, 68, 73, 79, 81, 102, 108]. Overall, studies
present contradictory findings about the relationship be-
tween understanding and adherence [38, 44, 46, 57, 63,
65, 66, 70, 81, 94, 103, 107, 113]. For some patients, a lack
of understanding and inadequate knowledge about
the medication [47] and prevention of a complication
[50, 52, 59] results in poorly controlled blood glucose
levels and poor adherence [43, 50, 52, 56, 69, 71, 82,
91, 101]. In other instances, patients report that they
understood medications’ importance, but not how the
medications work [17, 40, 44, 53, 59, 78, 85, 91, 97, 103].
Thus, patients often report abstaining from medication
when asymptomatic, or they consciously decide to take
medication according to how they feel [17, 62, 69, 76].
Other studies describe patients as knowledgeable, but
unable to translate this knowledge into appropriate
action (e.g. “what to do when things go wrong”) [40,
91, 103, 108, 114]. This kind of understanding may
improve with experience [44, 51, 94, 97], necessitating
a set of problem solving strategies [51, 102, 115], in-
cluding creative solutions to diabetes self-management
[68, 94, 97, 100, 102]. In light of these contradictory
findings we may conclude that the role of information
and understanding varies in importance depending on
individual circumstances.
Patients value the information received by their pro-
viders on medication treatment, self-management strat-
egies and on navigating the health care system [19, 38,
43, 48, 52, 57, 70, 78]. Patients also value the informa-
tion provided by a variety of ancillary resources, such
as clinic dieticians and nutritionists and peer support
groups [22, 47, 49, 55, 57] and educational programs,
including self-management education classes and medica-
tion counselling services [19, 38, 48, 55, 65, 68, 70, 92, 97].
Additionally, patients note that they appreciate the oppor-
tunity to share information and knowledge, and learn
from others who live with the same condition who suc-
cessfully cope with their condition [22, 45–50, 52, 53, 55,
58, 68, 76, 88, 91]. However, patients also identify the need
or desire for more information and management strategies
[19, 38, 47–49, 53, 55, 66, 105, 108], especially in language
and culture-specific ways [88, 91, 107, 116].
Providers describe patients’ lack of sufficient know-
ledge about the disease as one of the primary reasons
underlying poor medication adherence [17, 84, 110].
As this provider reports, ‘Oh, I probably said that it
[the cholesterol] was alright and then she thought is
was alright to stop, something like that, that's pos-
sible? That happens: they think everything is in order
again’ [95].
Providers also report a strong empathy for patients
around ideas such as the complexity and impact of
diabetes as an unpredictable, frustrating, and long-
term disease, identifying the importance of involving
and integrating all aspects of the patients’ life [75,
83]. Providers identify the following information pri-
orities for patients: integrated knowledge acquisition
about the nature of the disease, medications used and
how they work, lifestyle factors (diet, nutrition, exer-
cise), self-care, monitoring procedures, underlying
processes of diabetes, and the relationship between
diabetes symptoms, medication, and long term conse-
quences [19, 20, 75, 82]. Providers consider discussions
about medication-related issues, and improvement of
patients’ medication knowledge, important to promot-
ing medication adherence [66, 75, 82, 84, 85, 95].
Providers also recognize language barriers, which limit
a more in-depth conversation about a patient's cir-
cumstances and health beliefs [20, 110].
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Medication administration
For many patients, the administration of medication poses
a significant barrier to adherence. Patients describe fear as
a common barrier to insulin administration, in particular
fear of needles, fear of consequences of administering in-
sulin incorrectly, and the pain of injection or blood testing
[37, 38, 41, 44, 46, 49, 50, 58, 69, 71, 73, 83, 88, 113, 117].
Other patients specifically mention they were not afraid of
needles and did not find insulin injection painful [58]. Pa-
tients relate insulin administration to other psychological
barriers, such as a feeling of stigma around the possession
and use of an injectable medication because of the possi-
bility of being mistaken for an illicit drug [37, 38, 41, 50,
58, 68, 73, 88, 100, 102].
According to several studies, co-morbid conditions
represent a general barrier to medication administra-
tion [17, 22, 50, 57, 58, 66, 68, 77–80]. Patients who
take multiple medications may experience forgetfulness,
confusion about the purpose, name, and the potential for
interactions with other medications [43, 44, 50, 59, 62, 64,
78–80, 99, 105, 117]. The burden of the medication regi-
men is typically linked to the rigidity of medication which
impedes flexibility in every day life, as this patient re-
ports, ‘just the timing and remembering to take your
pills on time. It’s a real effort to take them at the
right time” [37, 50, 58, 61, 68, 73, 88, 102, 106, 108].
The development of habit-forming routines may en-
courage medication adherence [59, 108]. When the pa-
tient hasn’t established, or has disrupted, the routine,
medication adherence declines. This includes minor
(e.g. skipping meals) [17, 59, 68, 76, 78, 79, 91, 118], or
social and contextual factors in the patient’s life, such
as childcare, domestic duties, or work schedules can
interfere with patient’s routines [50, 61, 68, 94, 103].
Patients acknowledge family’s instrumental support as
a practical means to help integrate the treatment regi-
men in patients’ daily lives [17, 49–52, 54, 56–59, 66,
68–70, 76, 78, 118]. However, some patients describe
fear of being a burden on their family [49, 69, 77] or
unsupportive family members as a direct barrier to
medication adherence [17, 22, 37, 40, 48, 49, 52, 66, 68,
69, 77, 79, 118].
In general, providers do not recognize the adminis-
tration of medication as a potential barrier to adher-
ence, except in the case of patients with physical or
cognitive impairments [75,82,84], co-morbid condi-
tions [75, 83, 84], or related to treatments, for ex-
ample fear of needles upon initiation of insulin
treatment [20, 82, 84, 86, 110]. Healthcare providers
perceive family support as crucial for patients with
poor cognitive and physical resources,[82, 110] for re-
inforcing providers’ medication instructions, and for
holding the patient accountable for his/her self-
management [17, 82, 84, 110].
Social and cultural health beliefs
Health beliefs about medication and diabetes are often
linked to social or cultural understandings about the body,
diabetes and medication, which in turn can affect medica-
tion adherence in many different ways. Multiple factors
shape these health beliefs, such as the information sources
used by the patient, past experiences, attitudes of others,
faith and religious beliefs, education, and cultural commu-
nity [38, 41, 44, 48, 71]. A patient's health belief system
may affect the way he or she decides to approach medica-
tion adherence, and how to integrate (or not) the require-
ments of the medication regimen into everyday life [44, 76].
A patient's health beliefs and cultural background will
also affect the relationship s/he desires with the prescrib-
ing physician [44, 48, 50, 59, 60, 62, 69, 71, 72, 74, 89, 91,
117]. For instance, patients who are members of historic-
ally oppressed communities by the dominant culture can
be suspicious of medical advice [69, 71, 74, 89, 117]. Pa-
tients from cultures that perceive physicians as high status
individuals with significant authority may feel uncomfort-
able asking questions [20, 93, 98]. Several papers recom-
mend including the patient in a culturally appropriate way
as an active partner of care to improve medication adher-
ence [39, 41, 57, 58, 70, 93]. However, providers should
adapt to the patients’ beliefs and preferences, as some pa-
tients may refuse to work with clinicians in this way.
Social and cultural beliefs also affect patient preferences
for allopathic (Western biomedicine) compared to trad-
itional medications. Some patients express their intention
to take them alongside traditional medications [53, 56, 62,
74, 89]. Many patients indicate a preference for traditional
or herbal medications, and a suspicion or distrust of allo-
pathic medication [20, 44, 53, 62, 69, 79, 83, 88, 89, 92, 94,
116, 117]. These patients describe allopathic medicine as
unnatural [38, 44, 78, 79, 88, 92], the cause of side effects
and complications [20, 53, 62, 78, 88, 92, 117], incongru-
ent with their understanding of holistic health [20, 79, 88,
94]. In contrast, patients describe traditional remedies
as effective [88, 89, 92, 116], a link to their past and
present cultural communities [71, 88] and easier to
access [20, 88, 89].
Provider perspectives rarely address the issue of trad-
itional medication alongside or instead of allopathic medi-
cation [95]. Providers are more likely to mention
challenges linked with the patient's cultural background
and beliefs, such as aversion to insulin, fatalistic attitudes,
the perception that fat is healthier or a desire to please the
physician [20, 83, 84, 110, 112].
Financial issues
Patients widely mention the cost of medication as a bar-
rier to medication adherence [17–19, 37, 42, 44, 46, 50,
64, 68, 70, 75, 76, 81, 89, 91–93, 97, 119], although stud-
ies involving participants with access to public health
Brundisini et al. BMC Health Services Research  (2015) 15:516 Page 17 of 23
insurance less likely to mention cost as a barrier [47, 73].
Financial barriers can extend beyond the cost of medica-
tion and physician services. Even patients with health in-
surance can struggle to afford testing supplies, syringes,
and non-physician supportive care [17, 19, 37, 70, 75, 76,
81, 91, 92, 97]. Patients living in poverty also face other
structural and material constraints such as low health lit-
eracy, poor quality housing, shift work, stress, inability to
access healthy food etc., that affect their ability to adhere
to medication regimens [37, 68, 70, 89, 119]. When faced
with financial constraints, patients may use tactics includ-
ing: taking medication less often than recommended,
choosing the most “important” medication to pay for,
sharing pills with other people, drawing on personal cap-
abilities and social networks, and asking their doctor for
help [18, 50, 68, 89, 92].
Providers interviewed in some projects understand the
financial barriers that patients may face, but commonly
do not identify this issue as a barrier to medication ad-
herence [17, 18, 75, 83, 112]. In some cases, while pro-
viders may recognize that some patients struggle with
the cost of medication, ‘these were clearly secondary
concerns from the clinicians' perspective’ [18]. In several
instances, clinicians acknowledge the cost of medication
as a contextual barrier along with other struggles related
to low socio-economic status [83, 112]. While some cli-
nicians perceive that these struggles are outside of their
realm of influence [75], others offer creative strategies
for alleviating financial burden such as prescribing ge-
nerics, giving samples, changing the regimen to accom-
modate constraints or helping patients participate in
patient assistance programs [18, 75].
Discussion
Extensive qualitative research exists on the topic of barriers
to medication adherence amongst community-dwelling
adults with Type 2 diabetes. Our synthesis of this research
to date suggests that providers and patients share some
common understandings of these barriers, as well as facili-
tators to overcome them. However, the qualitative research
also identifies many points of misunderstanding, miscom-
munication, and missed opportunities for intervention. In
general, providers tend to limit their focus to clinically-
oriented issues, while patients describe a much wider range
of problems with medication adherence that arise from the
personal, social, and practical challenges of living with dia-
betes. To the extent providers understand and address
these wider concerns (possibly through a multidisciplinary
professional, patient-centered approach to care), they will
potentially improve both medication adherence and patient
experiences. This reflects what the literature addresses as
patient-models of care, where patients adhere to medica-
tions and not comply (emphasis added) overtaking past pa-
ternalistic models of care [6, 16, 120].
Our synthesis on medication adherence may contribute
to define more clearly the key dimensions of the person-
centered (PC) model of care and illustrate how this model
may improve medication adherence among Type 2 dia-
betic patients. According to Bower and Mead [16], PC
care is based on the following dimensions: inclusion of
biopsychosocial factors, viewing the patient as a person,
enhancing patient’s empowerment and autonomy, involv-
ing the patient in the decision-making process through a
two-way communication process and negotiation, encour-
aging a collaborative and mutual trusting relationship be-
tween patient and provider, and emphasizing the doctor
as a person.
Our study shows that patients and providers often
agree on the importance of medication adherence for
symptom improvement, the benefit of a collaborative
and responsive relationship between patient and pro-
vider, and effective communication of information. The
integration of patient’s perspectives in the clinical rela-
tionship, based on a mutual and trusting relationship,
broadens the scope of the explanatory model of illness
by addressing different ‘dysfunctional’ states and the pos-
sible interventions areas to improve adherence [7, 10,
16, 120–122]. As the PC model of care describes, these
factors help patients integrate their medication regimen
into their own system of health beliefs, the individual
context of their everyday lives, and their changing cir-
cumstances [10, 16, 120, 121, 123, 124].
Conversely, patients commonly cite providers’ lack of
collaboration, lack of interest in the patient’s life and
context, poor communication, or time constraints as
interfering with their medication adherence. Providers
on the other hand, as documented in recent studies
[125–127], tend to address systemic barriers, such as
limited time consultations and lack of inter-professional
collaboration, as obstacles challenging the prioritization
of patients’ medical and psychosocial needs.
Providers and patients differ significantly on how
best to influence patients’ self-management practices.
Providers tend to focus on patients’ knowledge about
the physiology of the disease and role of medical and
lifestyle interventions: i.e., the nature of the problem,
what needs to be done, and how. While some pro-
viders do recognize the importance of emotions and
psychosocial factors, providers relate these more to
the motivation, than to the capacity, to use medica-
tion properly. Recent studies corroborate these find-
ings, indicating that providers consider motivation as
crucial for patients’ understanding of the illness and
effective medical education [126, 128].
Patients, however, describe diabetes and medication
self-management as a multi-dimensional experience. Prac-
tical aspects include finances, daily routines, and the need
for instrumental support. Psychosocial aspects include
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health beliefs, emotional impacts, social and cultural
understandings of diabetes and medications. Self-
management models based on behaviour and integra-
tion theories reflect this perspective on medication
adherence behaviours and self-care activities, acknow-
ledging both the psychosocial and biomedical nature
of the medication regimen [129, 130] and highlighting
that perceptions may differ between patients and pro-
viders on treatments goals and strategies [131]. Pro-
viders’ focus on biomedical problem-solving can also
leave patients feeling “reduced to their disease”. This
runs counter to the person- or patient-centered care
approach that calls for treating people holistically,
with their attention to their disease placed in context
of attention to other factors in their lives [16, 121, 123].
All of these factors influence the way that patients inter-
pret and apply medical advice.
This synthesis of the qualitative research on patient
and provider perspectives underscores the recom-
mended shift from the traditional medical view of medi-
cation “compliance” to the more patient-centered view
of medication “concordance” with patients’ many other
needs, pressures and demands [7, 10, 13, 16, 121, 123].
Strengths and the limitations
A number of strengths and limitations of this study are
worth noting. First, this study provides an updated and
comprehensive qualitative systematic synthesis of Type 2
diabetes patients’ and providers’ different perspectives
on medication adherence. Existing systematic reviews of
qualitative research focus on diabetes management more
broadly [122, 132–134], and quantitative reviews on
medication adherence elicit different types of informa-
tion. For example, quantitative studies concentrate on
measuring medication adherence rates among Type 2
diabetes patients, or measuring medication adherence
rates for specific drug therapies, nutrition regimens and
educational interventions designed to improve adher-
ence, rather than addressing the reasons and experiences
of trying to adhere to medication regimes [12, 135–139].
By comparing patient and provider perspectives on this
issue, we are able to provide an interpretive synthesis of
the constellation of challenges that patients may face
when prescribed a medication regime for their diabetes.
Another strength of this study is the large body of
qualitative research available for synthesis on this topic:
we were able to include 86 studies that together cap-
tured thousands of patients’ experiences. The integrative
meta-synthesis method also allowed us to distil robust
thematic findings, each supported by a number of stud-
ies and therefore more transferable across settings. The
rigor of the synthesis allows establishing generalizability
and consistency of the findings among a large number of
studies and across different countries, patient population
groups, and patient demographic differences. A signifi-
cant portion of the included articles (33 out of 86) fo-
cused on very specific populations of diabetic patients,
such as indigenous groups, immigrants, and minorities.
We used a constant comparative technique to examine
medication adherence barriers across such groups in our
analysis and found our main categories to be consistent
across groups, with some variation in the sub-categories.
For example, we noted the consistency of the theme of
the importance of the patient-provider relationship
across studies that included marginalized and non-
marginalized populations. Comparative analysis of this
theme revealed that the patient-physician relationship
was consistently mentioned as important by authors of
both types of studies, although they tended to focus on
different aspects of this relationship. For example, mar-
ginalized participants spoke about the difficulty in com-
municating with language and cultural barriers and the
impediments that this provided to a strong, supportive
relationship with their physician. Non-marginalized
participants were more likely to focus on barriers such
as wait times and short length of appointments. Both
groups emphasized the importance of this relationship
on their ability to self-manage their diabetes. Similarly,
the results did not present consistent differences by age
or gender across study populations, as the populations
were overall consistent in terms of age and gender. We
found that barriers to medication adherence were con-
sistent across the different diabetic and demographic
populations considered in the 86 studies. Therefore we
are not presenting the results as stratified along these
lines. Findings concerning culture in particular may be
less transferable to jurisdictions and cultures not cap-
tured in this body of research. A limitation of this study
is its focus on English-language research reports.
This study was limited also in other ways. First, this
review includes only research conducted between 2002–
2013. These dates reflect an attempt to include a man-
ageable body of current literature. Given the depth and
complexity of qualitative data, 86 studies provide a large
body of data to describe and interpret. The WHO report
on medication adherence published in 2003 [1] offers an
authoritative summary of the state of knowledge before
2002; we have provided a review of this foundational lit-
erature in the introduction of the current manuscript.
Second, this meta-synthesis retrieved a great num-
ber of patient experiences reflecting a limitation of
the underlying body of research: the relatively fewer
qualitative research into providers’ perspective on
patient-barriers to medication adherence among Type
2 diabetes patients. Recent studies corroborate our re-
sults reinforcing the sense of saturation of our data
[125–128, 131], however, because studies on patient,
not provider, perspectives continue to dominate the
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field, we highlight providers as an important popula-
tion for future qualitative investigation and possibly
multi-methodology research syntheses.
Conclusion
This study synthesized Type 2 diabetes patients’ and pro-
viders’ views about medication adherence, highlighting
that these groups have different medication adherence pri-
orities. While providers tend to focus on patients’ motiva-
tions and medication administration practices, patient
accounts emphasize their experience of diabetes as part of
a holistic consideration of their whole lives. Providers
shared clinically oriented perspectives, detailing rich and
sophisticated conditional reasoning about their efforts to
persuade patients to adhere to their medication regimen.
Patients’ accounts of medication adherence describe indi-
vidual experiences of diabetes medication that are deeply
embedded within the context of the individual’s particular
life circumstances, emphasizing that medication self-man-
agement practices are built upon more than just know-
ledge and motivation for change. The conceptual divide
between patients and providers on the topic medication
adherence enriches our understanding of why medication
adherence may be experienced as an intractable issue by
both patients and providers. The findings of this synthesis
may assist providers in identifying potential factors that
affect a particular patient’s medication practices. Taking a
patient-centered approach to medication self-management
may encourage increased understanding the priorities and
experiences patients, encouraging providers to identify the
multiple underlying factors that promote or inhibit medi-
cation adherence in their patients creating the opportunity
for patients to voice their questions or concerns about
their medication regimens. Interventions that aim to im-
prove medication adherence will benefit from considering
the issue of adherence from a patient-centered model of
care by tailoring the medication regimen to patients’ life
contexts, preferences and self-management practices.
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